Haichang Biotech's 3 Products Obtain Marketing Approval from Thailand FDA for Medical Devices

ASEAN Finance Special Report (Total 300 articles)

Grasp the New Southbound Policy and look at the economic pulse of ASEAN. CNA's "Southeast Asia Financial Information Network" selects multiple financial headlines from Thailand, Vietnam, Indonesia, Malaysia, the Philippines, and other countries daily. Whether it's new government policies, industry trends, or investment opportunities, we provide you with timely key information to understand the market and seize business opportunities.

(CNA Taipei, July 7) Haichang Biotech announced today that its Haichang Collagen Regenerative Membrane, Collagen Bone Filler, and Collagen Matrix have obtained marketing approval from the Thailand FDA for CLASS 4 medical devices, the highest risk category. This is expected to increase sales performance in the Thai market and contribute to revenue.

Haichang Biotech was established in 2006, focusing on the field of collagen medical devices. Its core products cover dental wound protection materials, collagen matrices, collagen regenerative membranes, and bone fillers, with applications spanning the dental and surgical markets.

He Xin-yu, General Manager of Haichang Biotech, previously stated that the company will develop with a dual engine of "deepening penetration of existing products" and "innovative development of high-end medical devices." On one hand, it will expand its market layout in Southeast Asia and globally. On the other hand, it will enter the animal medical field and increase the proportion of high-margin products. As the application of regenerative medicine continues to expand and multiple new products are gradually introduced, the company's operating scale and profitability are expected to increase simultaneously. 1150707

Stand with facts, your every contribution supports the power of press freedom

Download the CNA "One-Hand News" APP to get the latest news in real-time

No reproduction, public broadcast, public transmission, or use of the text, images, or videos on this website is permitted without authorization.